Immunity
51
3
4
31
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 40/100
0.0%
0 terminated out of 51 trials
100.0%
+13.4% vs benchmark
14%
7 trials in Phase 3/4
3%
1 of 31 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.6%
Based on 31 completed trials
Clinical Trials (51)
Effects of TM02® Supplementation on Immune Function in Children
Precision Psychiatry for Depression: Immune Response and Affective Symptoms as Predictors of Response to Antidepressants
Childhood Infection and Immunity Longitudinal Cohort
Immune and Cognitive Benefits of Mango Intake in Young Adults
The Bloom Infant Probiotic (BIP) Study
Effects of LP28 on Immunity Enhancement in the Elderly
Understanding Immunity to the Flu Vaccine in COVID-19 Patients
Analysis of Psychoneuroimmunological Parameters of Health in Specific Population Groups in Slovakia
Effects of Bacillus Coagulans SNZ 1969 on Immune Health in Healthy School-aged Children
PFAS Exposure and Immune Response to Vaccination in Adults
Innate Immunity, MIcrobiota and Inovative Treatments in Endometriosis
Comparison of the Effects of Aerobic-Anaerobic Exercises on Hormonal and Immune Biomarkers
Efficacy of Twinkle Eyez Supplementation in Improving Ocular Health and Immunity
Effect of Protocatechuic Acid on Biochemical Markers of Immunity Status in Healthy Adults
COVID-19 Vaccination AZV 2021-2023
Clinical Study on the Effect of Probiotic Compound Powder on the Immunity Improvement of Preschool Children
Impact of Solarplast® on Immunity in Active Smokers and Non-smokers
Immunity Period After One Dose of Yellow Fever Vaccine in Adults and Children (Paraiba Study)
Study on Immune Status of Patients With COVID-19
Mechanisms of Inflammation, Immunity, Islet Cell and Intestinal Hormone Changes in Youth at Risk for Diabetes